KR101274779B1 - Poweder Composition Comprising Sugar-coated Pyssilum Husk - Google Patents
Poweder Composition Comprising Sugar-coated Pyssilum Husk Download PDFInfo
- Publication number
- KR101274779B1 KR101274779B1 KR1020100124988A KR20100124988A KR101274779B1 KR 101274779 B1 KR101274779 B1 KR 101274779B1 KR 1020100124988 A KR1020100124988 A KR 1020100124988A KR 20100124988 A KR20100124988 A KR 20100124988A KR 101274779 B1 KR101274779 B1 KR 101274779B1
- Authority
- KR
- South Korea
- Prior art keywords
- sugar
- powder
- coated
- weight
- parts
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 239000010903 husk Substances 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract description 71
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 31
- 235000010355 mannitol Nutrition 0.000 claims abstract description 29
- 229930195725 Mannitol Natural products 0.000 claims abstract description 27
- 239000000594 mannitol Substances 0.000 claims abstract description 27
- 239000008280 blood Substances 0.000 claims abstract description 23
- 210000004369 blood Anatomy 0.000 claims abstract description 23
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 18
- 206010060904 Freezing phenomenon Diseases 0.000 claims abstract description 5
- 239000013589 supplement Substances 0.000 claims abstract description 3
- 239000003610 charcoal Substances 0.000 claims description 17
- 238000004806 packaging method and process Methods 0.000 claims description 10
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 4
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 4
- 235000015872 dietary supplement Nutrition 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 240000009088 Fragaria x ananassa Species 0.000 claims description 3
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 2
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 2
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 2
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 2
- 235000021014 blueberries Nutrition 0.000 claims description 2
- 235000004634 cranberry Nutrition 0.000 claims description 2
- 238000009495 sugar coating Methods 0.000 claims 1
- 235000013325 dietary fiber Nutrition 0.000 abstract description 24
- 239000003795 chemical substances by application Substances 0.000 abstract description 7
- 235000013376 functional food Nutrition 0.000 abstract description 7
- 238000003860 storage Methods 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 238000009826 distribution Methods 0.000 abstract description 4
- 230000037406 food intake Effects 0.000 abstract description 4
- 239000000654 additive Substances 0.000 abstract description 2
- 230000000996 additive effect Effects 0.000 abstract description 2
- 241001122767 Theaceae Species 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 14
- 239000011812 mixed powder Substances 0.000 description 13
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 11
- 229910052782 aluminium Inorganic materials 0.000 description 11
- 235000012239 silicon dioxide Nutrition 0.000 description 9
- 239000000377 silicon dioxide Substances 0.000 description 9
- 238000007711 solidification Methods 0.000 description 9
- 230000008023 solidification Effects 0.000 description 9
- URRHWTYOQNLUKY-UHFFFAOYSA-N [AlH3].[P] Chemical compound [AlH3].[P] URRHWTYOQNLUKY-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 6
- 239000002657 fibrous material Substances 0.000 description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 6
- 210000000214 mouth Anatomy 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000000811 xylitol Substances 0.000 description 6
- 235000010447 xylitol Nutrition 0.000 description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 6
- 229960002675 xylitol Drugs 0.000 description 6
- 235000013373 food additive Nutrition 0.000 description 5
- 239000002778 food additive Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- 229920002774 Maltodextrin Polymers 0.000 description 4
- 239000005913 Maltodextrin Substances 0.000 description 4
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 4
- 229940107187 fructooligosaccharide Drugs 0.000 description 4
- 229940035034 maltodextrin Drugs 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 3
- 229910002012 Aerosil® Inorganic materials 0.000 description 3
- 229920001100 Polydextrose Polymers 0.000 description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 3
- 238000005054 agglomeration Methods 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 239000002075 main ingredient Substances 0.000 description 3
- 239000000845 maltitol Substances 0.000 description 3
- 235000010449 maltitol Nutrition 0.000 description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 3
- 229940035436 maltitol Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000001259 polydextrose Substances 0.000 description 3
- 235000013856 polydextrose Nutrition 0.000 description 3
- 229940035035 polydextrose Drugs 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 150000005846 sugar alcohols Chemical class 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 235000019216 blueberry extract Nutrition 0.000 description 2
- 229940055416 blueberry extract Drugs 0.000 description 2
- 235000020237 cranberry extract Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000002528 anti-freeze Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
- A23P20/10—Coating with edible coatings, e.g. with oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Preparation Of Fruits And Vegetables (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 배변활동 원활을 목적으로 하는 식이섬유 보충용 건강기능식품 조성물에 관한 것으로서, 더욱 상세하게는 당 코팅 차전자피와 과즙 분말에 만니톨을 추가로 포함하는 분말 조성물에 관한 것이다.
본 발명의 분말 조성물은 불용성 식이섬유를 포함하는 건강기능식품으로 물에 대한 용해성 및 섭취 용이성이 개선된 당 코팅 차전자피와 소비자 기호도를 만족시킬 수 있는 과즙 추출 분말과의 혼합물에, 일반적으로 사용되는 식품 첨가물인 고결방지제를 사용하지 않고 만니톨을 첨가하여, 보존 및 유통기간 동안 분말이 서로 엉기고 굳어지는 고결현상이 개선되어 있다.The present invention relates to a dietary fiber supplement health functional food composition for the purpose of smooth bowel movements, and more particularly to a powder composition further comprising mannitol in sugar-coated tea blood and juice powder.
The powder composition of the present invention is a health functional food containing insoluble dietary fiber, and is generally used in a mixture of sugar-coated cha-cha blood with improved water solubility and ease of ingestion and a juice extract powder that can satisfy consumer preference. By adding mannitol without using an additive anti-caking agent, the freezing phenomenon in which the powders are entangled and solidified during the storage and distribution periods is improved.
Description
본 발명은 불용성 식이섬유를 주원료로 하는 분말 제형의 식이섬유 보충용 건강기능식품 조성물로, 당 코팅 차전자피와 과즙 분말 및 만니톨을 함유하는 것을 특징으로 하는 분말 조성물에 관한 것이다. The present invention relates to a dietary supplement composition for supplementing dietary fiber of a powder formulation containing insoluble dietary fiber as a main ingredient, and relates to a powder composition comprising sugar-coated tea bar blood, juicer powder and mannitol.
건강기능식품 중 식이섬유는 배변활동을 원활히 하는데 도움을 주는 기능성을 가지고 있다. 이는 식이섬유의 섭취로 소화기관 내에서의 우수한 보수성, 유기화합물 흡착능력, 겔 형성능력, 대변의 양 증가로 인한 소화기관의 움직임을 활발히 하는 능력 등에 기인한다. Among dietary supplements, dietary fiber has functional properties that help to facilitate bowel movements. This is due to the intake of dietary fiber, excellent water retention in the digestive tract, organic compound adsorption capacity, gel formation ability, the ability to activate the digestive system movement due to the increase in the amount of feces.
따라서, 식품의약품안전청은 식이섬유를 보충할 수 있는 원료로서 구아검, 구아검 가수분해물, 글루코만난, 귀리, 난소화성말토덱스트린, 대두식이섬유, 목이버섯, 밀식이섬유, 보리식이섬유, 아라비아검, 옥수수겨, 이눌린/치커리 추출물, 차전자피, 폴리덱스트로스 및 호로파 종자 등 다양한 소재를 통한 식이섬유 섭취를 권하고 있다. 또한 상기 식이섬유 소재에 대한 일일 권장 섭취량을 설정하여 제시하고 있는데, 소재에 따라 차이가 있지만 일일 최소 3g에서 최대 50g을 섭취했을 때 목적하는 식이섬유의 기능성을 나타낼 수 있다. Therefore, the Korea Food and Drug Administration (KFDA) can supplement dietary fiber with guar gum, guar gum hydrolyzate, glucomannan, oats, indigestible maltodextrin, soybean dietary fiber, woody mushroom, wheat dietary fiber, barley dietary fiber, gum arabic, Dietary fiber intake is recommended through a variety of materials, including corn bran, inulin / chicory extract, chaff, polydextrose and fenugreek seeds. In addition, it is suggested to set the recommended daily intake for the dietary fiber material, there is a difference depending on the material, but may indicate the functionality of the desired dietary fiber when ingested at least 3g to 50g per day.
식이섬유 소재를 이용하여 건강기능식품을 제조하고자 할 때 검토할 수 있는 제형은 정제, 캅셀, 환, 과립, 액상, 분말 등 다양하지만, 난소화성말토덱스트린, 폴리덱스트린 등 수용성 식이섬유 소재와 달리 차전자피 등 불용성 식이섬유 소재는 제품 개발에 있어서 많은 제약을 받고 있다. When preparing a dietary supplement using dietary fiber materials, there are various formulations that can be reviewed, such as tablets, capsules, pills, granules, liquids, and powders.However, unlike water-soluble dietary fiber materials such as indigestible maltodextrin and polydextrin, Insoluble dietary fiber materials are subject to many limitations in product development.
수용성 식이섬유는 이미, 이취가 적고 입에서 쉽게 녹을 수 있는 특징을 가지지만, 불용성 식이섬유 소재는 물과 혼합하였을 때, 수 초 내에 급격하게 수분을 흡수, 겔상을 형성하여 액상 형태의 제품 개발이 불가능하며, 소재 고유의 냄새를 가지고 섭취 중 구강 전반에 걸쳐 입천장과 이 사이 및 입 주변에 부착되는 특징을 가지고 있어, 직접 입에 닿는 츄어블 정제, 분말 등의 제품 개발에 제약이 있다. 또한 3g 이상의 일일 섭취량을 만족시키기 위해, 1정당 200 내지 500mg의 정제 또는 환 사이즈를 가지는 제품으로 개발했을 시, 부형제를 고려하여 약 8 내지 20 정제 또는 환을 섭취해야 하는 등 섭취에 어려움을 가지고 있다.Water-soluble dietary fiber already has few odor and can easily dissolve in the mouth, but insoluble dietary fiber material absorbs moisture rapidly in a few seconds when mixed with water, It has a characteristic odor of the material and attaches to the mouth of the mouth and the mouth between the oral cavity during ingestion. Therefore, there are restrictions on the development of products such as chewable tablets and powders that directly touch the mouth. In addition, in order to satisfy the daily intake of 3g or more, when developed into a product having a tablet or tablet size of 200 to 500mg per tablet, it is difficult to intake about 8 to 20 tablets or pills in consideration of excipients .
이런 섭취의 어려움을 해결하기 위해 한국등록특허 10-0880650, 10-0486630에는 차전자피에 올리고당, 자일리톨 등 용해성과 친수성이 뛰어난 식용재료로 당 코팅을 하여 구강으로 섭취 또는 물에 용해를 용이하게 하는 방법이 개시되어 있다. 상기 당 코팅 차전자피의 경우, 물에 용해했을 때 일반 차전자피와 달리 물 보다 비중이 높아 뭉침 없이 잘 풀리고, 용해도 쉬운 장점을 가지고 있다. In order to solve this difficulty of ingestion, Korean Patent Registration 10-0880650, 10-0486630 has a method of coating sugar with soluble and hydrophilic food ingredients such as oligosaccharides and xylitol in car blood to facilitate ingestion or dissolution in water. Is disclosed. In the case of the sugar-coated chaff blood, when dissolved in water, unlike ordinary chaff blood, the specific gravity is higher than water, so it does not clump well and has an advantage of easy solubility.
하지만 불용성 식이섬유의 섭취 용이성을 향상시킨 당 코팅 차전자피를 이용하여 제품을 개발하고자 할 때, 당 코팅 식용재료로 사용된 올리고당 및 자일리톨 등은 조해성, 흡습성이 높은 물질로서 고온 다습한 조건에서 장기 보관 시 당 코팅 차전자피 분말이 서로 엉기어 굳어지는 고결현상을 보였으며, 특히 제품의 맛에 대한 기호도를 높이기 위해 주로 첨가되는 과즙 분말과 혼합하였을 때, 항온항습기 보관 시 수 일 내에 고결 현상을 보였다. 이와 같은 문제점은, 일일 섭취량을 만족시키며, 쉽게 섭취할 수 있는 불용성 식이섬유를 주원료로 하는 분말 제형 건강기능식품 보존 및 유통에 있어서 큰 문제점으로 지적되고 있는 부분이다. However, when developing products using sugar-coated charcoal with improved intake of insoluble dietary fiber, oligosaccharides and xylitol used as sugar-coated food ingredients are highly deliquescent and hygroscopic, which can be stored for long-term storage under high temperature and humidity conditions. The sugar-coated charcoal powder showed entangled stiffness, and especially when mixed with the juice powder, which is added mainly to increase the taste of the product, it showed solidification within several days of storage. This problem, which satisfies the daily intake, and has been pointed out as a major problem in the preservation and distribution of dietary functional foods containing the insoluble dietary fiber as a main ingredient that can be easily ingested.
따라서 당업계에서는 물에 대한 용해성 및 섭취 용이성이 개선된 당 코팅 차전자피와 소비자 기호도를 만족시킬 수 있는 과즙 추출 분말과의 혼합 분말 제조 시 발생되는 고결 현상을 개선하는 노력이 필요한 실정이다. Therefore, there is a need in the art for an effort to improve the solidification phenomenon generated during the production of a powder mixture of sugar-coated charcoal with improved water solubility and easy intake and juice extract powder that can satisfy consumer preference.
본 발명자들은 식이섬유 보충을 목적으로 하는 건강기능식품인 당 코팅 차전자피와 과즙 분말의 혼합 분말 조성물의 상기와 같은 종래 문제점을 극복하기 위하여 연구를 계속한 결과, 만니톨을 함께 혼합한 경우에, 식품 첨가물인 고결방지제 사용없이도, 당 코팅 차전자피와 과즙 분말 혼합 분말 조성물에서 야기되었던 고결 현상이 놀랍게 개선되는 효과를 확인하고 본 발명을 완성하게 되었다. The present inventors continued to overcome the above-mentioned problems of the mixed powder composition of sugar-coated Cha-Phi and the juice powder, which is a health functional food for the purpose of supplementing dietary fiber, and when mannitol is mixed together, a food additive Even without the use of a phosphorus freezing agent, it was confirmed that the solidification phenomenon caused by the sugar-coated charcoal and juice powder mixed powder composition was surprisingly improved and completed the present invention.
따라서 본 발명의 목적은 다습한 상태에서 보관 중 발생하는 분말 입자의 엉기고 굳어지는 고결 현상을 개선한 당 코팅 차전자피 분말 조성물을 제공하는 것을 목적으로 한다. Therefore, it is an object of the present invention to provide a sugar-coated chaff blood powder composition which improves the lumping and solidifying phenomenon of powder particles generated during storage in a humid state.
상기 목적을 달성하기 위하여, 본 발명은 당 코팅 차전자피 분말, 과즙 분말 및 만니톨을 포함하는 분말 조성물을 제공한다.In order to achieve the above object, the present invention provides a powder composition comprising a sugar-coated chaff blood powder, fruit juice powder and mannitol.
본 발명의 분말 조성물은 차전자피 분말 100 중량부를 기준으로 과즙 분말은 1 내지 15 중량부를 함유하고, 만니톨은 20 내지 50 중량부를 함유한다. 과즙추출물의 함량이 1 중량부 보다 낮으면 기호도가 떨어지고 15 중량부 보다 높으면 분말이 굳는 현상이 증가한다. 또한,만니톨의 함량은 20 중량부 보다 낮게 혼합되었을 때는 당 코팅 차전자피와 과즙 분말이 혼합되어 저장 또는 유통과정 중에 발생되는 고결 현상에 대한 개선 효과가 떨어지고, 50 중량부 보다 높게 혼합되었을 때는 개선 효과는 상승되지만 위장, 소장에서 거의 흡수되지 않고 대장에 도달하기 때문에 일과성의 설사를 유발할 수 있다.The powder composition of the present invention contains 1 to 15 parts by weight of the juice powder and 20 to 50 parts by weight of mannitol based on 100 parts by weight of the chaff powder. If the content of the fruit extract is lower than 1 part by weight, the preference decreases, and if it is higher than 15 parts by weight, the powder hardens. In addition, when the content of mannitol is lower than 20 parts by weight, the sugar-coated charcoal and the fruit juice are mixed to improve the freezing effect that occurs during the storage or distribution process, when higher than 50 parts by weight of the improvement effect It is elevated, but it is rarely absorbed by the stomach or small intestine and reaches the large intestine, which can cause hot diarrhea.
본 발명에 있어서, '당 코팅 차전자피 분말'이라 함은 차전자피의 섭취에 대한 불편함을 개선하고자 차전자피 분말 표면에 당분을 입히는 공정을 거친 분말을 말한다. 코팅에 사용되는 당분으로는 자일리톨, 프락토올리고당, 트레할로스, 에리스리톨, 말티톨, 환원물엿 등으로 이루어진 군 중에서 선택된 1종 이상의 것으로 정의할 수 있다.In the present invention, the sugar-coated chaff blood powder refers to a powder that has undergone a process of coating sugar on the chaff blood powder surface in order to improve discomfort in the intake of chaff blood. The sugar used for the coating may be defined as one or more selected from the group consisting of xylitol, fructooligosaccharide, trehalose, erythritol, maltitol, reduced syrup, and the like.
본 발명에 있어서, '과즙 분말'이라 함은 과일 농축액을 덱스트린을 비롯한 부형제에 분무 건조시킨 형태의 분말을 말하며, 과일로서는 복분자, 매실, 블루베리, 딸기 및 크랜베리 등으로 이루어진 군 중에서 선택된 1종 이상의 것으로 정의할 수 있다.In the present invention, the 'juice powder' refers to a powder in a form in which the fruit concentrate is spray-dried to an excipient including dextrin, and the fruit is one or more selected from the group consisting of bokbunja, plum, blueberry, strawberry, cranberry and the like. It can be defined as.
본 발명에 있어서, '만니톨'이라 함은 포도당 시럽이나 설탕으로부터 얻어진 과당을 촉매 반응시켜 수소첨가에 의해 제조하는 6탄당 당알콜로서, 만니트라고도 한다. 또한, 만니톨은 헥시트의 하나로 D, L, D·L형 등 3종의 이성질체가 있으며, 통상적으로 만니톨이라고 하면 D-만니톨을 의미한다. In the present invention, 'mannitol' is a hexasaccharide sugar alcohol prepared by hydrogenation by catalytic reaction of fructose obtained from glucose syrup or sugar and is also referred to as mannite. In addition, mannitol is one of the hexets, and there are three kinds of isomers such as D, L, and D-L type, and mannitol generally means D-mannitol.
본 발명의 분말 조성물은 바람직하게는 스틱 포장, 사면포장, 병포장 등의 형태일 수 있으며, 그외 다양한 휴대용 분말 제형의 건강기능식품 일 수 있다. The powder composition of the present invention is preferably in the form of stick packaging, four-pack packaging, bottle packaging, etc., may be a health functional food of various other portable powder formulations.
본 발명에 따른 당 코팅 차전자피 분말 조성물은, 당 코팅 차전자피를 주원료로 하고 소비자의 기호도를 만족시키는 과즙 분말을 함유하는 건강기능식품 분말 제형 제조에 있어서, 기존의 이산화규소 등 화학성분 고결방지제의 추가 없이, 장내 유익 미생물 증식에 도움을 주며 장 운동에 도움을 주는 소재인 만니톨을 첨가하는 것으로 고결현상이 방지된 건강 기능식품을 제공할 수 있다.The sugar-coated charcoal powder composition according to the present invention, in the manufacture of a health functional food powder formulation containing a sugar-coated charcoal blood as the main ingredient and satisfying consumer's preference, without the addition of conventional chemical anti-caking agent such as silicon dioxide In addition, by adding mannitol, a material that helps the growth of beneficial intestinal microorganisms and helps intestinal exercise, it is possible to provide health functional foods in which solidification is prevented.
따라서 본 발명에 따른 당 코팅 차전자피 분말 조성물은 고결방지제 대신에 만니톨을 사용함으로써 제품의 제조 및 유통과정 중 발생할 수 있는 고결현상을 방지되어 제품의 안전성을 확보하고, 식이섬유가 가지는 기능성인 배변활동 및 장 건강에 시너지 효과를 가지며, 최근 식품 첨가물의 사용을 배제 또는 최소화하려는 식품 업계의 트랜드를 반영하므로 산업적 효과가 매우 크다고 할 수 있다. Therefore, the sugar-coated charcoal powder composition according to the present invention uses mannitol instead of the anti-caking agent to prevent freezing phenomenon that may occur during the manufacturing and distribution process of the product to ensure the safety of the product, the functional bowel activity and dietary fiber has It has a synergistic effect on intestinal health and reflects the trend of the food industry to exclude or minimize the use of food additives in recent years, so the industrial effect is very large.
도 1은 종래의 당 코팅 차전자피와 과즙 분말의 혼합 분말 (참고예 1) 및 고결방지제인 이산화규소를 첨가한 당 코팅 차전자피 분말 조성물 (비교예 1)의 항온항습기에서 48 시간 보관 후의 분말 형태를 나타낸다.
도 2는 참고예 2~8, 실시예 1 및 비교예 2의 분말 조성물을 항온항습기에서 72 시간 보관 후의 분말 형태를 나타낸다. 1 shows a powder form after storage for 48 hours in a constant temperature and humidity chamber of a sugar-coated charcoal powder composition (Comparative Example 1) to which a sugar-coated charcoal-coated blood and juice powder is mixed (Reference Example 1) and silicon dioxide as an anti-caking agent. .
Figure 2 shows the powder form after storing the powder compositions of Reference Examples 2 to 8, Example 1 and Comparative Example 2 in a thermo-hygrostat for 72 hours.
이하, 본 발명의 이해를 돕기 위하여 구체적인 실시예 및 비교예를 통하여 본 발명의 구성 및 효과를 보다 상세히 설명하기로 한다. 그러나 하기 실시예는 본 발명을 보다 명확하게 이해시키기 위하여 예시한 것일 뿐이며, 본 발명의 권리범위가 하기 실시예에 의해 한정되는 것은 아니다. Hereinafter, the configuration and effects of the present invention will be described in more detail with reference to specific examples and comparative examples in order to help understanding of the present invention. However, the following examples are only illustrated to more clearly understand the present invention, and the scope of the present invention is not limited by the following examples.
실험예Experimental Example 1 One
참고예 1Reference Example 1
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 복분자 추출물, 매실 추출물, 블루베리 추출물, 딸기 추출물 및 크랜베리 추출물 중 선택된 1종의 과즙 분말(세계에프엘) 15 중량부 혼합하여, 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다. 15 parts by weight of one juice powder selected from Bokbunja extract, plum extract, blueberry extract, strawberry extract, and cranberry extract in 3.2 g of sugar-coated Cha-Pae (Jungeun Healthcare Co., Ltd.) By mixing, the mixed powder was packaged in 4 g in an aluminum stick pouch which is a general packaging form of powder formulation.
비교예 1Comparative Example 1
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준으로 복분자 추출물, 매실 추출물, 블루베리 추출물, 딸기 추출물 및 크랜베리 추출물 중 선택된 1종의 과즙 분말 15 중량부, 이산화규소(식품첨가물, Aerosil®) 0.4중량부 혼합하여, 혼합분말을 알루미늄 스틱 파우치에 4g 포장하였다.To 3.2 g of sugar-coated Cha-Pae (Jungeun Healthcare Co., Ltd.), 15 parts by weight of one juice powder selected from Bokbunja Extract, Plum Extract, Blueberry Extract, Strawberry Extract, and Cranberry Extract, based on 100 parts by weight of Sugar-coated Cha-Pae Extract, Silicon Dioxide ( by mixing a food additive, 0.4 part by weight of Aerosil ®), and packaged 4g mixed powder in an aluminum stick pouch.
상기 참고예 1 및 비교예 1을 온도 40℃, 상대습도 80%의 항온항습기 조건에서의 48시간 보관한 후, 스틱 파우치를 개봉하여 확인한 분말 제형의 사진을 도 1에 나타내었다.After storing the Reference Example 1 and Comparative Example 1 in a constant temperature and humidity conditions of 40 ℃, a relative humidity of 80% for 48 hours, a photograph of the powder formulation confirmed by opening the stick pouch is shown in FIG.
도 1에서 확인할 수 있듯이, 참고예 1과 같이 종래의 당 코팅 차전자피와 과즙 분말 혼합 분말의 경우 분말 입자가 엉기어 파우치 모양으로 굳어지는 현상이 48시간 내에 뚜렷이 나타났다. 반면에 고결방지제인 이산화규소를 0.4 중량부 혼합한 비교예 1의 경우, 고결 현상이 뚜렷이 방지되는 것을 확인할 수 있다. As can be seen in Figure 1, in the case of the conventional sugar-coated charcoal blood and juice powder mixed powder, as shown in Reference Example 1, the phenomenon that the powder particles were entangled and hardened into a pouch shape was apparent within 48 hours. On the other hand, in Comparative Example 1 in which 0.4 parts by weight of silicon dioxide, which is an anti-caking agent, it was confirmed that the freezing phenomenon was clearly prevented.
실험예Experimental Example 2 2
참고예 2Reference Example 2
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15 중량부, 프락토올리고당(㈜삼양제넥스) 30 중량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다.The powder is mixed with 3.2 g of sugar-coated cha-e-p (Jungeun Healthcare), 15 parts by weight of 100% by weight of sugar-coated cha-e-p, (30 F), and 30 parts by weight of fructooligosaccharide (Samyang Genex). 4g was packaged in a stick pouch made of aluminum, which is a general packaging form.
참고예 3Reference Example 3
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15 중량부, 말티톨(로케트) 30 중량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다.The sugar powder is mixed with 3.2 g of Jeongeun Healthcare Co., Ltd., 100 parts by weight of sugar-coated charcoal extract, 15 parts by weight of plum extract (World F.L), and 30 parts by weight of maltitol (rocket). Packed in 4g aluminum stick pouch.
참고예 4Reference Example 4
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15 중량부, 트레할로스 30 중량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다. The powder is mixed with 3.2g of sugar-coated Cha-Pae (Jungeun Healthcare Co., Ltd.), 15 parts by weight of Plum Extract (World F.L), and 30 parts by weight of trehalose based on 100 parts by weight of sugar-coated Cha-Pa. 4 g was packed in a stick pouch.
참고예 5Reference Example 5
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15 중량부, 자일리톨(로케트) 30 중량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다. Sugar powder is mixed with 3.2g of Jeongeun Healthcare Co., Ltd., 15 parts by weight of plum extract (World F.L), and 30 parts by weight of xylitol (rocket) based on 100 parts by weight of sugar-coated charcoal blood. Packed in 4g aluminum stick pouch.
참고예 6Reference Example 6
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15 중량부, 솔비톨(로케트) 30 중량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다.The sugar powder is mixed with 3.2 g of Jeongeun Healthcare Co., Ltd., 100 parts by weight of sugar-coated charcoal extract, 15 parts by weight of plum extract (World F.L), and 30 parts by weight of sorbitol (rocket). Packed in 4g aluminum stick pouch.
참고예 7Reference Example 7
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15 중량부, 폴리덱스트로스(㈜삼양제넥스) 30 중량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다. The mixed powder is mixed with 3.2 g of sugar-coated Cha-P (Jungeun Healthcare Co., Ltd.), 15 parts by weight of Plum Extract (World F.L), and 30 parts by weight of Polydextrose (Samyang Genex), based on 100 parts by weight of Sugar-coated Cha-P. 4g was packaged in a stick pouch made of aluminum.
참고예 8Reference Example 8
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15 중량부, 난소화성말토덱스트린(로케트) 30 중량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다. Sugar powder is mixed with 3.2g of Jeongeun Healthcare Co., Ltd., 15 parts by weight of plum extract (World F.L) and 30 parts by weight of indigestible maltodextrin (rocket) based on 100 parts by weight of sugar-coated charcoal blood. 4g was packaged in a stick pouch made of aluminum.
실시예 1Example 1
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15 중량부, 만니톨(Amechem®) 30 중량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다. The mixed powder is mixed with 3.2 g of sugar-coated Cha-Pi (Jungeun Healthcare Co., Ltd.), 15 parts by weight of Plum Extract (World F.L.), 30 parts by weight of mannitol (Amechem ® ), based on 100 parts by weight of sugar-coated Cha-Pi. 4g was packaged in a stick pouch of phosphorus aluminum.
비교예 2Comparative Example 2
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15 중량부, 이산화규소 (식품첨가물, Aerosil?) 0.4중 량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다. The powder mixture is mixed with 3.2 g of sugar-coated Cha-Pi (Jungeun Healthcare Co., Ltd.), 15 parts by weight of Plum Extract (World F.L.), 0.4 parts by weight of silicon dioxide (Food additive, Aerosil ? ) 4g was packaged in a stick pouch made of aluminum, which is a general packaging form.
상기 참고예, 실시예 및 비교예를 온도 40℃, 상대습도 80%의 항온항습기 조건에서의 보관하면서 24시간 간격으로 고결현상 정도를 평가하여 표 1에 나타내었다. 또한 보관 72시간 후 분말형태의 사진을 도 2에 나타내었다. The reference examples, examples and comparative examples are shown in Table 1 by evaluating the degree of freezing phenomenon at intervals of 24 hours while storing in a constant temperature and humidity conditions of 40 ℃, relative humidity 80%. In addition, the photo of the powder form 72 hours after storage is shown in FIG.
(+ 분말상이나 약간의 응집, ++~++++ 응집정도 증가, +++++ 파우치 모양으로 굳음, - 분말상 유지)Integrity
(+ Powdery or slight agglomeration, ++ ~ ++++ agglomeration increased, +++++ pouch shape,-powdery)
상기 표 1에 나타낸 바와 같이, 고결현상은 시간이 흐름에 따라 증가하는 양상을 보였으며, 도 2에 나타낸 바와 같이, 72시간 후 알루미늄 스틱 파우치를 개봉한 결과, 당 코팅 차전자피와 과즙 분말 및 각각 혼합한 당알콜과 수용성 식이섬유는 분말이 응집하여 굳어지는 양상을 보였다. 고결정도는 프락토올리고당, 자일리톨, 폴리덱스트를 첨가한 참고예에서 가장 높게 나타났다. 반면에 만니톨을 첨가한 본 발명에 따른 분말 조성물에서는 고결현상이 일어나지 않았고, 고결방지제인 이산화규소를 첨가한 비교예 2와 유사한 고결방지 효과를 나타냈다. As shown in Table 1, the solidification phenomenon was shown to increase with the passage of time, as shown in Figure 2, after opening the aluminum stick pouch after 72 hours, the sugar-coated chaff blood and juice powder and mixed respectively One sugar alcohol and water-soluble dietary fiber showed agglomeration and solidification of the powder. High crystallinity was highest in the reference example with fructooligosaccharide, xylitol, and polydexter. On the other hand, in the powder composition according to the present invention to which mannitol was added, no solidification phenomenon occurred, and the anti-freezing effect was similar to that of Comparative Example 2 in which silicon dioxide, which is an antifreezing agent, was added.
상기에서 확인할 수 있듯이, 당알콜 및 수용성 식이섬유 소재 중에서 유일하게 만니톨을 첨가하였을 때 당 코팅 차전자피와 과즙 분말 혼합 분말에서 야기 되었던 고결 현상이 개선되는 효과를 얻었다.As can be seen from the above, when only mannitol was added among sugar alcohols and water-soluble dietary fiber materials, the solidification phenomenon caused by sugar-coated charcoal blood and juice powder powder was obtained.
실험예Experimental Example 3 3
실시예 2Example 2
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15 중량부, 만니톨(Amechem?) 5 중량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다. The mixed powder is mixed with 3.2 g of sugar-coated chaff blood (Jungeun Healthcare Co., Ltd.), 15 parts by weight of plum extract (World F.L) and 5 parts by weight of mannitol (Amechem ? ), Based on 100 parts by weight of sugar-coated chaff blood . 4g was packaged in a stick pouch of phosphorus aluminum.
실시예 3Example 3
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15 중량부, 만니톨(Amechem?) 10 중량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다. The mixed powder is mixed with 3.2 g of sugar-coated Cha-P (Jungeun Healthcare Co., Ltd.), 15 parts by weight of Plum Extract (World F.L), and 10 parts by weight of mannitol (Amechem ? ), Based on 100 parts by weight of sugar-coated Cha-P . 4g was packaged in a stick pouch of phosphorus aluminum.
실시예 4Example 4
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15 중량부, 만니톨(Amechem?) 20 중량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다. The mixed powder is mixed with 3.2 g of sugar-coated Cha-P (Jungeun Healthcare Co., Ltd.), 15 parts by weight of Plum Extract (World F.L), and 20 parts by weight of mannitol (Amechem ? ) Based on 100 parts by weight of Sugar-coated Cha-P . 4g was packaged in a stick pouch of phosphorus aluminum.
실시예 5Example 5
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15 중량부, 만니톨(Amechem?) 30 중량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다. The mixed powder is mixed with 3.2 g of sugar-coated Cha-Pae (Jungeun Healthcare Co., Ltd.), 15 parts by weight of Plum Extract (World F.L) and 30 parts by weight of mannitol (Amechem ? 4g was packaged in a stick pouch of phosphorus aluminum.
실시예 6Example 6
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15중량부, 만니톨(Amechem?) 40 중량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다. The mixed powder is mixed with 3.2 g of sugar-coated Cha-P (Jungeun Healthcare Co., Ltd.), 15 parts by weight of Plum Extract (World F.L) and 40 parts by weight of mannitol (Amechem ? ), Based on 100 parts by weight of sugar-coated Cha-P . 4g was packaged in a stick pouch of phosphorus aluminum.
실시예 7Example 7
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15 중량부, 만니톨(Amechem?) 50 중량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다. The mixed powder is mixed with 3.2 g of sugar-coated chaff blood (Jungeun Healthcare Co., Ltd.), 15 parts by weight of plum extract (World F.L) and 50 parts by weight of mannitol (Amechem ? ), Based on 100 parts by weight of sugar-coated chaff blood . 4g was packaged in a stick pouch of phosphorus aluminum.
비교예 3Comparative Example 3
당 코팅 차전자피(㈜정은헬스케어) 3.2g에, 당 코팅 차전자피 100 중량부 기준 매실 추출물 (세계에프엘) 15 중량부, 이산화규소 (식품첨가물, Aerosil?) 0.4 중량부 혼합하여 혼합 분말을 분말 제형의 일반적인 포장 형태인 알루미늄 재질의 스틱 파우치에 4g 포장하였다. Powder mixture is mixed with 3.2g of sugar-coated Cha-Phi Co., Ltd. (Jungeun Healthcare Co., Ltd.), 15 parts by weight of Plum Extract (World F.L), 0.4 parts by weight of silicon dioxide (Food additive, Aerosil ? ) 4g was packaged in a stick pouch made of aluminum, which is a general packaging form.
상기 실시예 및 비교예의 분말제형을 온도 40℃, 상대습도 80%의 항온항습기 조건에서 1주일간 보관 후, 고결 형성 정도를 평가하기 위하여 체(체눈 850 ㎛)를 통과시켜 체에 남는 분말의 중량%를 표 2에 나타내었다. The powder formulations of Examples and Comparative Examples were stored for 1 week in a constant temperature and humidity condition at a temperature of 40 ° C. and a relative humidity of 80%, and then passed through a sieve (solid 850 μm) to evaluate the degree of solidification. Is shown in Table 2.
표 2에 나타낸 바와 같이, 만니톨 5 중량부 첨가시 12.25 중량%의 입자가 체에 남았으며, 만니톨 10 중량부 첨가시 8.5 중량%의 입자가 체에 남아서, 비교예 3과 비교했을 때 고결현상이 일어났다. 그러나 만니톨 20 내지 50 중량부를 첨가하였을 때는 비교예 3과 같이 고결 방지효과를 가지는 것으로 확인되었다. As shown in Table 2, 12.25% by weight of particles remained in the sieve when 5 parts by weight of mannitol was added, and 8.5% by weight of particles remained in the sieve when 10 parts by weight of mannitol was added. woke up. However, when 20 to 50 parts by weight of mannitol was added, it was confirmed to have an anti-caking effect as in Comparative Example 3.
Claims (6)
당 코팅 차전자피 및 과즙 분말의 혼합물에 만니톨을 추가로 포함하고,
상기 만니톨은 당 코팅 차전자피 100 중량부 기준으로 20 내지 50 중량부인 것을 특징으로 하는 분말 조성물.Sugar-coated chaff blood powder composition prevented freezing phenomenon,
Further comprises mannitol in a mixture of sugar-coated chaff and juice powder,
The mannitol is a powder composition, characterized in that 20 to 50 parts by weight based on 100 parts by weight of sugar-coated charcoal.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100124988A KR101274779B1 (en) | 2010-12-08 | 2010-12-08 | Poweder Composition Comprising Sugar-coated Pyssilum Husk |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100124988A KR101274779B1 (en) | 2010-12-08 | 2010-12-08 | Poweder Composition Comprising Sugar-coated Pyssilum Husk |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120089876A KR20120089876A (en) | 2012-08-16 |
KR101274779B1 true KR101274779B1 (en) | 2013-06-25 |
Family
ID=46883126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100124988A KR101274779B1 (en) | 2010-12-08 | 2010-12-08 | Poweder Composition Comprising Sugar-coated Pyssilum Husk |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101274779B1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102673223B1 (en) * | 2018-10-31 | 2024-06-07 | (주)아모레퍼시픽 | Granular Composition Comprising Dietary Fiber from Green Tea and Method for Preparing the Same |
KR102658628B1 (en) * | 2023-04-28 | 2024-04-19 | 노비스바이오 주식회사 | Functional composition containing sugar coated psyllium hull powder |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0127646B1 (en) * | 1994-01-13 | 1997-12-26 | 김용언·로버트. 엘. 오디 | Dietary fiber food, and processing method of it |
JP2007504207A (en) * | 2003-09-05 | 2007-03-01 | アロー・ナンバー7・リミテッド | Intraoral drug delivery |
-
2010
- 2010-12-08 KR KR1020100124988A patent/KR101274779B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0127646B1 (en) * | 1994-01-13 | 1997-12-26 | 김용언·로버트. 엘. 오디 | Dietary fiber food, and processing method of it |
JP2007504207A (en) * | 2003-09-05 | 2007-03-01 | アロー・ナンバー7・リミテッド | Intraoral drug delivery |
Also Published As
Publication number | Publication date |
---|---|
KR20120089876A (en) | 2012-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI109648B (en) | Directly compressible xylitol and process | |
JP5224606B2 (en) | Probiotic oral dosage form | |
US7229641B2 (en) | Rapid-melt compositions methods of making same and methods of using same | |
Patel et al. | New pharmaceutical excipients in solid dosage forms-A review. | |
US20100010101A1 (en) | Rapid-Melt Compositions and Methods of Making Same | |
CN102089075A (en) | Manufacture process for the preparation of an iron containing phosphate adsorbent | |
CN101087615A (en) | N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same | |
SK74396A3 (en) | Organoleptically acceptable oral pharmaceutical compositions | |
JP4820288B2 (en) | Method for producing health food containing dietary fiber | |
AU2003205868B2 (en) | Improvements in or relating to compositions | |
CN104582731A (en) | Solid pharmaceutical preparation containing levothyroxine | |
WO2000066083A1 (en) | Folic acid supplement | |
US20120034302A1 (en) | Particulate composition and the method of making the same | |
KR101274779B1 (en) | Poweder Composition Comprising Sugar-coated Pyssilum Husk | |
WO2013183767A1 (en) | Solid food product with sugar-coating layer which includes functional component and production method thereof | |
JP2017105844A (en) | Internal composition | |
CN112293634B (en) | Seaweed powder solid beverage and preparation method thereof | |
CN101904536A (en) | Novel purely natural sugarless non-caloric functional sugar and preparation method thereof | |
JPH0827033A (en) | Erythritol-containing solid agent | |
CN105555316B (en) | Disintegrating granule composition produced by two-stage wet granulation process and intraorally disintegrating tablet containing the same | |
JP2002065213A (en) | Method for producing solid agent | |
MX2012013759A (en) | Orodispersible tablets of erythritol and isomalt. | |
US20220110900A1 (en) | Solid nutrient compositions and associated methods | |
JP2022174474A (en) | solid composition | |
JP2010252816A (en) | Compressed chewing gum tablet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20160304 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20170306 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20180308 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20200304 Year of fee payment: 8 |